SALIVARY CANCER
Clinical trials for SALIVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY CANCER trials appear
Sign up with your email to follow new studies for SALIVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a prostate cancer drug shrink salivary tumors?
Disease control OngoingThis study tests enzalutamide, a drug already approved for other cancers, in people with a certain type of salivary gland cancer that has spread or cannot be removed. The goal is to see if the drug can shrink tumors by at least 30% in at least 20% of participants. About 46 adults…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink tumors and to identify biomarkers that predict response. Participants receive pembrolizumab and are m…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 08:33 UTC